HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alun J Carter Selected Research

efineptakin alfa

1/2022A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alun J Carter Research Topics

Disease

1Neoplasms (Cancer)
01/2022
1Hematologic Neoplasms (Hematological Malignancy)
01/2022
1Weight Loss (Weight Reduction)
01/2017
1Cytokine Release Syndrome
01/2017
1Body Weight (Weight, Body)
01/2017
1Edema (Dropsy)
01/2017
1Traumatic Brain Injuries (Traumatic Brain Injury)
09/2014
1Brain Injuries (Brain Injury)
09/2014

Drug/Important Bio-Agent (IBA)

1efineptakin alfaIBA
01/2022
1Chimeric Antigen ReceptorsIBA
01/2022
1Interleukin-7 (Interleukin 7)IBA
01/2022
1SuperantigensIBA
01/2017
1staphylococcal enterotoxin BIBA
01/2017
1Abatacept (Orencia)FDA Link
01/2017
1Biological ProductsIBA
09/2014
1Chemotactic FactorsIBA
09/2014

Therapy/Procedure

1Aftercare (After-Treatment)
01/2017